Literature DB >> 24790137

Stem cell factor is a potent endothelial permeability factor.

Ji Yeon Kim1, Jun-Sub Choi1, Sun-Hwa Song1, Ji-Eun Im1, Jung-Mo Kim1, Kyungjong Kim1, Soonboem Kwon1, Hwa Kyoung Shin1, Choun-Ki Joo1, Byung Ho Lee1, Wonhee Suh2.   

Abstract

OBJECTIVE: Although stem cell factor (SCF) has been shown to play a critical role in hematopoiesis, gametogenesis, and melanogenesis, the function of SCF in the regulation of vascular integrity has not been studied. APPROACH AND
RESULTS: We demonstrated that SCF binds to and activates the cKit receptor in endothelial cells, thereby increasing the internalization of vascular endothelial-cadherin and enhancing extravasation of dyes to a similar extent as vascular endothelial growth factor. SCF-mediated cKit activation in endothelial cells enhanced the phosphorylation of endothelial nitric oxide (NO) synthase via the phosphoinositide 3-kinase/Akt signaling pathway and subsequently increased the production of NO. Inhibition of endothelial NO synthase expression and NO synthesis using small interfering RNA knockdown and chemical inhibitors substantially diminished the ability of SCF to increase the internalization of vascular endothelial-cadherin and in vitro endothelial permeability. SCF-induced increase in extravasation of the dyes was abrogated in endothelial NO synthase knockout mice, which indicates that endothelial NO synthase-mediated NO production was responsible for the SCF-induced vascular leakage. Furthermore, we demonstrated that the expression of SCF and cKit was significantly higher in the retina of streptozotocin-injected diabetic mice than in the nondiabetic control animals. Depletion of SCF by intravitreous injection of anti-SCF-neutralizing immunoglobulin G significantly prevented vascular hyperpermeability in the retinas of streptozotocin-injected diabetic mice.
CONCLUSIONS: Our data reveal that SCF disrupts the endothelial adherens junction and enhances vascular leakage, as well as suggest that anti-SCF/cKit therapy may hold promise as a potential therapy for the treatment of hyperpermeable vascular diseases.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  nitric oxide synthase type III; stem cell factor; vascular permeability

Mesh:

Substances:

Year:  2014        PMID: 24790137     DOI: 10.1161/ATVBAHA.114.303575

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

Review 1.  Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.

Authors:  Alicia N Rizzo; Jurjan Aman; Geerten P van Nieuw Amerongen; Steven M Dudek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-26       Impact factor: 8.311

2.  c-Kit deficiency impairs nitric oxide signaling in smooth muscle cells.

Authors:  Diana R Hernandez; Miguel G Rojas; Laisel Martinez; Boris L Rodriguez; Zachary M Zigmond; Roberto I Vazquez-Padron; Roberta M Lassance-Soares
Journal:  Biochem Biophys Res Commun       Date:  2019-08-12       Impact factor: 3.575

3.  A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors.

Authors:  Jin-Ock Kim; Kwang-Hyeok Kim; Eun Ji Baek; Bomi Park; Min Kyung So; Byoung Joon Ko; Han-Jik Ko; Sang Gyu Park
Journal:  Mol Oncol       Date:  2021-08-29       Impact factor: 6.603

4.  Perivascular Progenitor Cells Derived From Human Embryonic Stem Cells Exhibit Functional Characteristics of Pericytes and Improve the Retinal Vasculature in a Rodent Model of Diabetic Retinopathy.

Authors:  Jung Mo Kim; Ki-Sung Hong; Won Kyung Song; Daekyeong Bae; In-Kyu Hwang; Jong Soo Kim; Hyung-Min Chung
Journal:  Stem Cells Transl Med       Date:  2016-07-07       Impact factor: 6.940

5.  Src tyrosine kinase regulates the stem cell factor-induced breakdown of the blood-retinal barrier.

Authors:  Ji-Eun Im; Sun-Hwa Song; Wonhee Suh
Journal:  Mol Vis       Date:  2016-10-13       Impact factor: 2.367

6.  c-Kit modifies the inflammatory status of smooth muscle cells.

Authors:  Lei Song; Laisel Martinez; Zachary M Zigmond; Diana R Hernandez; Roberta M Lassance-Soares; Guillermo Selman; Roberto I Vazquez-Padron
Journal:  PeerJ       Date:  2017-06-13       Impact factor: 2.984

7.  High expression of CXCR4 and stem cell markers in a monocrotaline and chronic hypoxia-induced rat model of pulmonary arterial hypertension.

Authors:  Tingting Zhang; Nanako Kawaguchi; Emiko Hayama; Yoshiyuki Furutani; Toshio Nakanishi
Journal:  Exp Ther Med       Date:  2018-04-03       Impact factor: 2.447

8.  Proteomic profiling identifies key differences between inter-stage infants with single ventricle heart disease and healthy controls.

Authors:  Benjamin S Frank; Ludmila Khailova; Lori Silveira; Max B Mitchell; Gareth J Morgan; Elena W Y Hsieh; Michael V DiMaria; Mark Twite; Jelena Klawitter; Jesse A Davidson
Journal:  Transl Res       Date:  2020-10-09       Impact factor: 7.012

9.  Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage.

Authors:  Ji Hoon Jeong; Hong Khanh Nguyen; Jung Eun Lee; Wonhee Suh
Journal:  Int J Nanomedicine       Date:  2016-07-07

10.  Human decidua basalis mesenchymal stem/stromal cells protect endothelial cell functions from oxidative stress induced by hydrogen peroxide and monocytes.

Authors:  M A Alshabibi; T Khatlani; F M Abomaray; A S AlAskar; B Kalionis; S A Messaoudi; R Khanabdali; A O Alawad; M H Abumaree
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.